
Unexplainable An Alzheimer's breakthrough?
68 snips
Oct 19, 2026 Dylan Scott, a senior Vox correspondent covering health and medical science, explores whether Alzheimer’s research is finally turning a corner. They discuss promising prevention strategies, new drugs that modestly slow decline, and a controversial surgery claiming to clear brain plaques. The conversation also examines the science behind the disease, desperate treatment choices, caregiver anguish, and why optimism still needs caution.
AI Snips
Chapters
Transcript
Episode notes
Why Alzheimer’s Research Lost Its Momentum
- Alzheimer’s treatment stagnated for decades, offering symptom relief but no way to slow the disease.
- A controversial FDA approval intensified doubts after advisors warned that benefits were weak and serious side effects substantial.
Alzheimer’s May Become Treatable
- Recent drugs, prevention ideas, and experimental surgery suggest Alzheimer’s could become treatable rather than inevitably identity-destroying.
- Scott emphasizes that a cure remains distant, with meaningful possibilities perhaps five, ten, or fifteen years away.
Alzheimer’s Has More Than One Cause
- Researchers link Alzheimer’s to amyloid plaques, tau tangles, inflammation, and vascular deterioration, but still describe this model cautiously.
- The disease appears multifaceted, disrupting brain signals as damaging processes accumulate with age.

